AIP
HRMY icon

Ameritas Investment Partners’s Harmony Biosciences HRMY Stock Holding History

Ameritas Investment Partners’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102K Hold
3,654
– – ﹤0.01% 1688
2025
Q4 		$137K Hold
3,654
– – ﹤0.01% 1508
2025
Q3 		$101K Sell
3,654
-812
-18% -$28K ﹤0.01% 1688
2025
Q2 		$141K Buy
4,466
+479
+12% +$15.4K ﹤0.01% 1508
2025
Q1 		$132K Hold
3,987
– – ﹤0.01% 1517
2024
Q4 		$137K Buy
3,987
+1,029
+35% +$35.4K ﹤0.01% 1571
2024
Q3 		$118K Hold
2,958
– – ﹤0.01% 1678
2024
Q2 		$89.2K Sell
2,958
-320
-10% -$9.62K ﹤0.01% 1804
2024
Q1 		$110K Hold
3,278
– – ﹤0.01% 1671
2023
Q4 		$106K Hold
3,278
– – ﹤0.01% 1695
2023
Q3 		$107K Buy
3,278
+554
+20% +$19.2K ﹤0.01% 1603
2023
Q2 		$95.9K Buy
2,724
+757
+38% +$26.1K ﹤0.01% 1625
2023
Q1 		$64.2K Hold
1,967
– – ﹤0.01% 1819
2022
Q4 		$96.5K Hold
1,967
– – ﹤0.01% 1627
2022
Q3 		$87K Hold
1,967
– – ﹤0.01% 1594
2022
Q2 		$95K Buy
1,967
+214
+12% +$9.63K ﹤0.01% 1545
2022
Q1 		$85K Hold
1,753
– – ﹤0.01% 1750
2021
Q4 		$75K Hold
1,753
– – ﹤0.01% 1859
2021
Q3 		$67K Hold
1,753
– – ﹤0.01% 1961
2021
Q2 		$49K Buy
1,753
+1,233
+237% +$37K ﹤0.01% 2202
2021
Q1 		$17K Hold
520
– – ﹤0.01% 2630
2020
Q4 		$19K Buy
+520
New +$21K ﹤0.01% 2497

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Ameritas Investment Partners's HRMY Position: Q1 2026 in Review

Ameritas Investment Partners held its Harmony Biosciences (HRMY) position steady in Q1 2026 at 3,654 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

Ameritas Investment Partners first reported a position in HRMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $141K in Q2 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Ameritas Investment Partners held 3,654 shares of Harmony Biosciences worth $102K as of Q1 2026.
  • Ameritas Investment Partners left its Harmony Biosciences share count unchanged in Q1 2026.
  • Harmony Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1688 holding.
  • Ameritas Investment Partners first reported a position in Harmony Biosciences in Q4 2020 and has held it in 22 quarters since.
  • Ameritas Investment Partners's Harmony Biosciences position peaked at $141K in Q2 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.